Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



EU Investigates Allegations Against Roche

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Europe's drug and pharmaceutical regulator, the European Medicines Agency (EMA), announced today that it has launched an investigation into Swiss pharmaceutical company Roche (NASDAQOTH: RHHBY  ) over allegations that the company failed to report side effects of its products.

The agency will look at whether the company upheld legal responsibilities to ensure its 19 products are safe for European markets, according to an EMA press release.

The investigation comes after a similar action by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA), which first pointed out potential flaws  in Roche's actions.

The EMA will pass on any findings to the European Commission, which could levy fines of up to 5% of all Roche's European Union sales.

Investigators from the MHRA identified up to 80,000 possible reports of side effects that the company hadn't handled properly. The claims include some of the company's biggest sellers, such as the influenza drug Tamiflu and cancer drug Avastin.

Roche said it was cooperating with authorities, and the EMA said  that all the company's drugs remained authorized for sale and use.

Dan Carroll has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2070754, ~/Articles/ArticleHandler.aspx, 10/26/2016 11:21:28 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 2 hours ago Sponsored by:
DOW 18,199.33 30.06 0.17%
S&P 500 2,139.43 -3.73 -0.17%
NASD 5,250.27 -33.13 -0.63%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/26/2016 3:59 PM
RHHBY $28.36 Down -0.26 -0.91%
Roche Holding Ltd.… CAPS Rating: *****